Thor J. Borgford

Chief Executive Officer at Twinstrand Therapeutics, Inc.

Consumer Services

Health Technology

Profile

Thor J.
Borgford has been President and Chief Executive Officer of Twinstrand Therapeutics, Inc. since 1995.
He is an Adjunct Professor in the Department of Chemistry and the Institute of Molecular Biology and Biochemistry at Simon Fraser University.
He was an Executive Director of the BC Biotechnology Alliance from 1997 to 1999.
He was Chairman of the Science Council of British Columbia's Biotechnology Grant Selection Committee from 1995 to 1996.
Dr. Borgford received a PhD from the University of Manitoba.

Thor J. Borgford active positions

Companies	Position	Start
Twinstrand Therapeutics, Inc. Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.	Chief Executive Officer	01/01/1995
Simon Fraser University	Corporate Officer/Principal	-

All active positions of Thor J. Borgford

Former positions of Thor J. Borgford

Companies	Position	End
BC Biotechnology Alliance	Director/Board Member	-

See the detail of Thor J. Borgford's experience

Training of Thor J. Borgford

University of Manitoba

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thor J. Borgford's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Twinstrand Therapeutics, Inc. Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.	Health Technology
BC Biotechnology Alliance